Effectiveness of nirsevimab against RSV-related outcomes: findings of the 2024-2025 campaign in Catalonia align with previous analysis
- PMID: 40499942
- DOI: 10.1136/archdischild-2025-329005
Effectiveness of nirsevimab against RSV-related outcomes: findings of the 2024-2025 campaign in Catalonia align with previous analysis
Keywords: Child Health; Infectious Disease Medicine; Respiratory Medicine.
Conflict of interest statement
Competing interests: AS-A have received funding from Sanofi, MSD and Pfizer for lectures and for attending international meetings and congresses. The other authors declare no competing interests.
Publication types
LinkOut - more resources
Full Text Sources